Hadasit

Canonic Will Conduct Pre-Clinical Studies into Cannabis at Hadassah

Canonic, a subsidiary of the biotechnology company Evogene Ltd., has announced an agreement with Hadasit, the Hadassah Medical Center’s Technology Transfer Company, to perform pre-clinical studies to support Canonic’s development…

Hadasit

First-Ever International Lifetime Achievement Award Goes to Hadassah Psychiatrist

...More than a Hospital

First in Israel: Hadasit Launches Medical Startup Accelerator with IBM

Hadasit

Hadassah Hosts Health Innovation Conference

ALS Research

Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial

...More than a Hospital

From Locked Jaw to Osteoarthritis: Hadassah Discovery Leads to New Treatment

Graft vs Host disease

Hadasit and Cellect Team Up for Stem Cell Innovation

Drugs and Antibiotics

Collaboration Announced to Develop Hadassah Drug to Treat “Untreatable” NASH Liver Disease

Cardiology Research

Hadassah Collaborates on Cannabinoid Drug to Treat Diabetes and Other Serious Illnesses

Cardiology Research

Clinical Trial Begins at Hadassah University Medical Center with New Drug To Treat Stroke

Hadasit

Medicine: Taking Stock of Hadassah–by Wendy Elliman (as appeared in Hadassah Magazine, January 2011 )

Genetics

From Research to Clinical Care: the Hadassah Medical Center’s Start-Ups

Hadasit

Hadasit Start-Up Company Develops Precursor To Vaccine for Rheumatoid Arthritis

Hadasit

Hadassah International

Canonic Will Conduct Pre-Clinical Studies into Cannabis at Hadassah

First-Ever International Lifetime Achievement Award Goes to Hadassah Psychiatrist

First in Israel: Hadasit Launches Medical Startup Accelerator with IBM

Hadassah Hosts Health Innovation Conference

Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial

From Locked Jaw to Osteoarthritis: Hadassah Discovery Leads to New Treatment

Hadasit and Cellect Team Up for Stem Cell Innovation

Collaboration Announced to Develop Hadassah Drug to Treat “Untreatable” NASH Liver Disease

Hadassah Collaborates on Cannabinoid Drug to Treat Diabetes and Other Serious Illnesses

Hadasit Sets Up Incubator Company to Develop Stent Locator

Diary of a Director General: From the Mind to the Marketplace

Thrombotech Receives Regulatory Approval for Stroke Medicine Trials in the US

Clinical Trial Begins at Hadassah University Medical Center with New Drug To Treat Stroke

Medicine: Taking Stock of Hadassah–by Wendy Elliman (as appeared in Hadassah Magazine, January 2011 )

From Research to Clinical Care: the Hadassah Medical Center’s Start-Ups

Hadasit Start-Up Company Develops Precursor To Vaccine for Rheumatoid Arthritis

Hadassah Research Breakthrough: New Hope for Stroke Victims